Page last updated: 2024-08-25

ljc 10627 and Hematologic Diseases

ljc 10627 has been researched along with Hematologic Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Azuma, R; Harada, H; Mori, H; Niikura, H; Omine, M; Sakai, H; Sanada, M; Shimamoto, K1

Trials

1 trial(s) available for ljc 10627 and Hematologic Diseases

ArticleYear
[Multicenter, retrospective study of biapenem in the treatment of 1090 cases with hematological diseases complicated with infections].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2013, Volume: 34, Issue:9

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Female; Hematologic Diseases; Humans; Male; Middle Aged; Retrospective Studies; Thienamycins; Treatment Outcome; Young Adult

2013

Other Studies

1 other study(ies) available for ljc 10627 and Hematologic Diseases

ArticleYear
[Clinical evaluation of biapenem for febrile neutropenia in patients with hematological disorders].
    The Japanese journal of antibiotics, 2007, Volume: 60, Issue:2

    Topics: Anemia, Aplastic; Carbapenems; Fever; Hematologic Diseases; Humans; Infusions, Intravenous; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma; Myelodysplastic Syndromes; Neutropenia; Thienamycins; Treatment Outcome

2007